Cargando…
Updated therapeutic outcome for patients with periampullary and pancreatic cancer related to recent translational research
Chemotherapy with improved effect in patients with metastatic pancreatic cancer has recently been established, launching a new era for patients with this very aggressive disease. FOLFIRINOX and gemcitabine plus nab-paclitaxel are different regimens, both capable of stabilizing the disease, thus incr...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5192261/ https://www.ncbi.nlm.nih.gov/pubmed/28082802 http://dx.doi.org/10.3748/wjg.v22.i48.10502 |